Annual Total Long Term Liabilities
$37.96 M
-$1.87 M-4.69%
31 December 2023
Summary:
Stoke Therapeutics annual total long term liabilities is currently $37.96 million, with the most recent change of -$1.87 million (-4.69%) on 31 December 2023. During the last 3 years, it has risen by +$34.01 million (+861.21%). STOK annual total long term liabilities is now -4.69% below its all-time high of $39.82 million, reached on 31 December 2022.STOK Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$11.34 M
-$9.21 M-44.82%
30 September 2024
Summary:
Stoke Therapeutics quarterly total long term liabilities is currently $11.34 million, with the most recent change of -$9.21 million (-44.82%) on 30 September 2024. Over the past year, it has dropped by -$26.62 million (-70.12%). STOK quarterly long term liabilities is now -78.62% below its all-time high of $53.06 million, reached on 31 March 2022.STOK Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
STOK Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -70.1% |
| 3 y3 years | +861.2% | +187.2% |
| 5 y5 years | +10000.0% | +5031.7% |
STOK Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -4.7% | +861.2% | -78.6% | +187.2% |
| 5 y | 5 years | -4.7% | >+9999.0% | -78.6% | +5031.7% |
| alltime | all time | -4.7% | >+9999.0% | -78.6% | >+9999.0% |
Stoke Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $11.34 M(-44.8%) |
| June 2024 | - | $20.55 M(-29.7%) |
| Mar 2024 | - | $29.25 M(-22.9%) |
| Dec 2023 | $37.96 M(-4.7%) | $37.96 M(-8.9%) |
| Sept 2023 | - | $41.69 M(-7.1%) |
| June 2023 | - | $44.89 M(+23.2%) |
| Mar 2023 | - | $36.45 M(-8.5%) |
| Dec 2022 | $39.82 M(+908.5%) | $39.82 M(-10.9%) |
| Sept 2022 | - | $44.69 M(-9.6%) |
| June 2022 | - | $49.46 M(-6.8%) |
| Mar 2022 | - | $53.06 M(+1243.5%) |
| Dec 2021 | $3.95 M | $3.95 M(-9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $4.37 M(+269.4%) |
| June 2021 | - | $1.18 M(+255.6%) |
| Mar 2021 | - | $333.00 K(-21.1%) |
| Dec 2020 | $422.00 K(+91.0%) | $422.00 K(-36.5%) |
| Sept 2020 | - | $665.00 K(-34.1%) |
| June 2020 | - | $1.01 M(-3.4%) |
| Mar 2020 | - | $1.04 M(+372.4%) |
| Dec 2019 | $221.00 K(+5425.0%) | $221.00 K(-3.1%) |
| Sept 2019 | - | $228.00 K(+1166.7%) |
| June 2019 | - | $18.00 K(+80.0%) |
| Mar 2019 | - | $10.00 K(+150.0%) |
| Dec 2018 | $4000.00(-75.0%) | $4000.00 |
| Dec 2017 | $16.00 K | - |
FAQ
- What is Stoke Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Stoke Therapeutics?
- What is Stoke Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Stoke Therapeutics?
- What is Stoke Therapeutics quarterly long term liabilities year-on-year change?
What is Stoke Therapeutics annual total long term liabilities?
The current annual total long term liabilities of STOK is $37.96 M
What is the all time high annual total long term liabilities for Stoke Therapeutics?
Stoke Therapeutics all-time high annual total long term liabilities is $39.82 M
What is Stoke Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of STOK is $11.34 M
What is the all time high quarterly long term liabilities for Stoke Therapeutics?
Stoke Therapeutics all-time high quarterly total long term liabilities is $53.06 M
What is Stoke Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, STOK quarterly total long term liabilities has changed by -$26.62 M (-70.12%)